We are thankful for our advisors, the scientists developing our assets and all those innovating for a better standard of care in the pain field. Stay hopeful and practice gratitude daily and we will learn to change the world.
关于我们
Cacti is a biotech company advancing FDA approved, first-in-class "Nociplastigens" to treat chronic pain, inflammation, and opioid use disorder. Our interdisciplinary team aims to understand the psychological drivers of pain and bring transformative therapies to the patients at the heart of our mission.
- 网站
-
www.cactitherapeutics.com
Cacti的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 总部
- Dallas ，Texas
- 类型
- 私人持股
- 创立
- 2022
地点
Cacti员工
动态
-
We envision a future where we repair the pain nerves instead of masking, numbing, or killing them. We also embrace the complexity of chronic pain instead of ignoring all the factors that make pain a subjective experience. While this episode is about fundraising, Kait hopes all entrepreneurs are inspired to create the world they desire with their innovations and find the true believers in their vision. #biotech #patternbreakers #drugdiscovery #femalefounders
Driving Growth & Expediting Deals in Life Science Through Strategic Business Development | Managing Partner, Sosna + Co | Dealmaker & Partnership Architect | Co-Host, #ScientistToCEO Podcast ??
New episode alert!??Today on the Scientist to CEO podcast, CEO of Cacti, Kaitlin Roberson schools us on the art of effective #fundraising - how she did it, tips you can use, and techniques that work. With a Master's in psychology from Harvard, and a background in non-profits, she has honed an effective approach?any CEO can use to: ?Find the right #investors ?Make your company message?make sense to anyone ?Build relationships that will pay dividends (literally) ?????????LISTEN NOW ?? https://buff.ly/3Bcqo58 ????????? Will you help us spread the word? Tag a fellow science professional in your network! — ???#ScientistToCEO is the business growth podcast for companies built by scientists. ?? Co-hosted by Jennifer Andrews, M.Sc., MBA & Erica Sosnowski Scientist to CEO?
-
Cacti's multi-modal, interdisciplinary approach to developing new therapies for chronic pain, is by design, not by accident!
Co-Founder & CEO @ Cacti Therapeutics | Philanthropic Leader | Motivational Speaker
This weekend, I’ve been preparing for a conference in Brazil in Oct., where I’ll be sharing insights from a developmental psychology perspective on the importance of the biopsychosocialspiritual lens on pain. The latest research in pain processing reveals how our biological, psychological, and social experiences interact, shaping our understanding of pain. How do different cultures view the role of pain and manage chronic pain? The deeper I get into the research the more fascinated I am about the role our development and culture plays in our experiences of pain.?Preparing these two talks is combining my love of psychology, anthropology and neuroscience! #PainManagement #BiopsychosocialModel #DevelopmentalPsychology #Conference
-
Take your vacation time. Breathe. Create. Refocus. #worklifebalance #laborday2024
-
-
Did you know that 7 out of every 10 deaths in the U.S. are due to chronic illness and the majority of those are preventable diseases? 1 in 4 people live with chronic pain...and it doesn't have to be this way. We need advocacy and education for policy changes and societal changes that center our wellness and equitable access to quality healthcare. The best chronic diseases are the ones we cure through research, innovation, collaboration, and community-based, culturally competent care! #istaystrong #chronicdiseaseday
-
-
We've held back on media coverage but the time is right and we're excited to get out there and showcase our amazing team and innovative tech!
Co-Founder & CEO @ Cacti Therapeutics | Philanthropic Leader | Motivational Speaker
Thanks Nicole Ward for this wonderful article featuring both Cacti and Blackbox. We are grateful to be a part of the growing Dallas ecosystem! ?? ?? ?? #biotech #Dallashub #chronicpain #ML #AI #drugdevelopment
-
Many people dread fundraising but these expert investors demystified this important process and encouraged us to take the time to check all the boxes for the funds we desire as partners. Yes, it's been a few tough years in biotech but the tide will turn because innovation therapies with great teams driving them forward are always needed!
Passionate about improving patients lives and addressing health disparities- Design Thinking Champion- Ambassador for Diversity, Equity & Inclusion- Extensive drug commercialization experience-Mentor to people & startups
Great DFW HBA event last night on Navigating Investments in Emerging Biotech/Pharma: Insights from Investors' Viewpoint!"sponsored by?#LydaHillPhilanthropies?and featuring panelists?John Vandermosten Amanda de la Garza,?Kaitlin Roberson, Sarah Stukalin and?Dan Trang. A great conversation with seasoned investors on evaluating potential start ups and positioning a company for fundraising success. #HBAimpact?#HBADFW?#HBAsouthwest?#Biotech?#Pharma?#StartupInvestments
-